Client & Alumni News
Successful patient’s tricuspid heart valve repair using new procedure and tools
Micro Interventional Devices, Inc.™ (MID) announced today the world’s first percutaneous implantation of its MIA, Minimally Invasive Annuloplasty, technology for tricuspid and mitral repair. This marks the first patient enrolled in the transcatheter arm of the STTAR (Study of Transcatheter Tricuspid Annular Repair) trial being conducted in Europe. More: https://bit.ly/2IYeAUI
